cremophor el has been researched along with phosphatidylcholines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, A; Straubinger, RM | 1 |
| Allen, C; De Souza, R; Grant, J; Piquette-Miller, M; Vassileva, V | 1 |
| Jain, S; Khandhuja, KL; Tiwary, AK; Utreja, P; Yadav, S | 1 |
3 other study(ies) available for cremophor el and phosphatidylcholines
| Article | Year |
|---|---|
Novel taxol formulations: preparation and characterization of taxol-containing liposomes.
Topics: Animals; Cell Division; Cell Line; Drug Carriers; Drug Stability; Drug Storage; Electrochemistry; Female; Glycerol; Humans; Liposomes; Mice; Mice, Inbred BALB C; Paclitaxel; Pharmaceutical Vehicles; Phosphatidylcholines; Phosphatidylglycerols | 1994 |
Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biocompatible Materials; Chitosan; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Implants; Eggs; Female; Glycerol; Humans; Injections, Intraperitoneal; Mice; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Phosphatidylcholines; Xenograft Model Antitumor Assays | 2007 |
Efficacy and toxicological studies of cremophor EL free alternative paclitaxel formulation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Cell Line, Tumor; Deoxycholic Acid; Dose-Response Relationship, Drug; Excipients; Female; Glycerol; Glycine max; Humans; Lethal Dose 50; Liposomes; Lung Neoplasms; Male; Maximum Tolerated Dose; Mice; Paclitaxel; Phosphatidylcholines | 2011 |